Global Patent Index - EP 1086212 A2

EP 1086212 A2 2001-03-28 - METHOD AND REAGENTS FOR THE TREATMENT OF DISEASES OR CONDITIONS RELATED TO MOLECULES INVOLVED IN ANGIOGENIC RESPONSES

Title (en)

METHOD AND REAGENTS FOR THE TREATMENT OF DISEASES OR CONDITIONS RELATED TO MOLECULES INVOLVED IN ANGIOGENIC RESPONSES

Title (de)

VERFAHREN UND WIRKSTOFFE ZUR BEHANDLUNG VON KRANKHEITEN UND ZUSTÄNDE DIE MIT ANGIOGENESE FAKTOREN ZUSAMMENHÄNGEN

Title (fr)

PROCEDE ET REACTIFS POUR LE TRAITEMENT DE MALADIES OU D'AFFECTIONS ASSOCIEES A DES MOLECULES IMPLIQUEES DANS LES REACTIONS ANGIOGENIQUES

Publication

EP 1086212 A2 (EN)

Application

EP 99915032 A

Priority

  • US 9906507 W
  • US 7967898 P

Abstract (en)

[origin: WO9950403A2] Nucleic acid molecule which modulate the synthesis, expression and/or stability of an mRNA encoding for angiogenic factors selected from aryl hydrocarbon nuclear transport (ARNT), intergrin subunit beta 3 ( beta 3), integrin subunit alpha 6 ( alpha 6) and tie - 2 RNA. This invention further provides a treatment for indications related to angiogenesis using the nucleic acid molecules.

[origin: WO9950403A2] Nucleic acid molecule which modulates the synthesis, expression and/or stability of an mRNA encoding for angiogenic factors selected from aryl hydrocarbon nuclear transport (ARNT), intergrin subunit beta 3 ( beta 3), integrin subunit alpha 6 ( alpha 6) and tie - 2RNA. This invention further provides a treatment for indications related to angiogenesis using the nucleic acid molecules.

IPC 1-7 (main, further and additional classification)

C12N 15/00; C07K 14/47; C12N 9/00

IPC 8 full level (invention and additional information)

C12N 15/09 (2006.01); A61K 31/7088 (2006.01); A61K 31/7125 (2006.01); A61K 35/76 (2006.01); A61K 48/00 (2006.01); A61P 3/10 (2006.01); A61P 17/06 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C12N 5/10 (2006.01); C12N 9/00 (2006.01); C12N 15/113 (2010.01); A61K 38/00 (2006.01)

CPC (invention and additional information)

C12N 15/113 (2013.01); C12N 15/1138 (2013.01); A61K 38/00 (2013.01); C12N 2310/111 (2013.01); C12N 2310/12 (2013.01); C12N 2310/121 (2013.01); C12N 2310/122 (2013.01); C12N 2310/124 (2013.01); C12N 2310/126 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/33 (2013.01)

Citation (search report)

See references of WO 9950403A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9950403 A2 19991007; WO 9950403 A3 20010118; WO 9950403 A9 20000316; AU 3364799 A 19991018; AU 757789 B2 20030306; CA 2324421 A1 19991007; EP 1086212 A2 20010328; JP 2002509721 A 20020402

INPADOC legal status


2006-01-11 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20050621

2005-03-30 [17Q] FIRST EXAMINATION REPORT

- Ref Legal Event Code: 17Q

- Effective date: 20050210

2001-03-28 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20001026

2001-03-28 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE